Mapspeople (MAPS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
23 Jan, 2026Executive summary
Total ARR grew 19% year-over-year to DKK 55.6M, with MapsIndoors ARR up 27% to DKK 40.9M, and recognized revenue increased 35% year-over-year to DKK 14.4M in Q2 2024.
EBITDA before special items improved by 48% year-over-year to negative DKK 8.2M, with cost reductions and staff down 19–20%.
Net Revenue Retention (NRR) held at 110%, mainly driven by US partner/customer expansions.
Guidance for 2024: ARR DKK 72–80M, revenue DKK 58–63M, EBITDA before special items negative DKK 20–25M.
Management is testing market options for a capital raise to support increased investment in Sales & Marketing and potential M&A.
Financial highlights
Recognized revenue for Q2 2024 was DKK 14.4M, up 35% year-over-year; 12-month rolling revenue reached DKK 50.3M.
EBITDA before special items was negative DKK 8.2M, a 48% improvement year-over-year.
Net loss for Q2 2024 was DKK 14.8M, improved from DKK 17.6M in Q2 2023.
Staff costs reduced by 19–20% year-over-year; depreciation increased due to completed development projects.
Earnings per share (basic) for Q2 2024 was DKK -0.18, improved from DKK -0.27 in Q2 2023.
Outlook and guidance
Revenue and EBITDA expected to accelerate in the second half as ARR growth flows through, with cost base now stable.
Guidance for 2024 remains unchanged despite increased investment in Sales & Marketing.
No further special items expected for the remainder of 2024; EBITDA after special items guidance negative DKK 22–27M.
No specific guidance for 2025, but cash flow positivity is expected before profitability due to prepaid contracts.
Guidance does not include potential impact from future acquisitions; positive effects from M&A could exceed current guidance.
Latest events from Mapspeople
- Strong ARR and revenue growth, improved EBITDA, and a DKK 36M capital raise nearly complete.MAPS
Q2 202423 Jan 2026 - Q3 2024 saw record revenue, improved EBITDA, and lower ARR guidance after a capital raise.MAPS
Q3 202414 Jan 2026 - Q3 2024 saw 9% ARR and 38% revenue growth, improved EBITDA, and a strong cash boost.MAPS
Q3 202414 Jan 2026 - 54% revenue growth, halved EBITDA loss, and strong ARR outlook for 2025.MAPS
Q4 202426 Dec 2025 - 54% revenue growth, halved EBITDA loss, and 2025 targets ARR growth of 33-35% with strong outlook.MAPS
Q4 202426 Dec 2025 - Apex acquired a majority stake, injecting DKK 39M as revenue and EBITDA improved.MAPS
Q1 202513 Nov 2025